SCHEMBL592010

SCHEMBL592010

Cc1ccc2nc(-c3ccc(N=C=O)cc3)sc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.62
KDM4E B2RXH2 9/20 0.62
NPC1 O15118 8/20 0.62
RAB9A P51151 8/20 0.62
APP P05067 5/20 0.62
GLA P06280 4/20 0.62
GAA P10253 4/20 0.62
SNCA P37840 1/20 0.59
ALDH1A1 P00352 7/20 0.53
HPGD P15428 5/20 0.53
RORC P51449 2/20 0.53
TP53 P04637 3/20 0.52
SMN1; SMN2 Q16637 6/20 0.51
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
LMNA P02545 2/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7526379 0.88 MAPT (0.49) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL11062046 0.84 MAPT (0.70) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL11062078 0.84 MAPT (0.70) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL12422217 0.82 MAPT (0.81) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL4600650 0.80 RAB9A (0.58) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL7531819 0.80 MAPT (0.72) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL12422096 0.78 APP (0.62) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL5349180 0.77 MAPT (0.72) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL492713 0.77 APP (1.00) MAPTKDM4ENPC1RAB9AAPP
SCHEMBL13453290 0.77 APP (1.00) MAPTKDM4ENPC1RAB9AAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11150358-B2 Radiation dosimetry sol or gel and radiation dosimeter comprising same as material for radiation dosimetry RIKEN (JP) 2021-10-19 US disclosed
US-20200333474-A1 RADIATION DOSIMETRY SOL OR GEL AND RADIATION DOSIMETER COMPRISING SAME AS MATERIAL FOR RADIATION DOSIMETRY RIKEN (JP) 2020-10-22 US disclosed
EP-3686632-A1 RADIATION DOSIMETRY SOL OR GEL AND RADIATION DOSIMETER COMPRISING SAME AS MATERIAL FOR RADIATION DOSIMETRY Riken (JP) 2020-07-29 EP disclosed
US-20170023681-A1 PERSONAL AND SELF INDICATING RADIATION ALERT DOSIMETER NEW YORK UNIVERSITY 2017-01-26 US disclosed
US-9086489-B2 Personal and area self-indicating instant radiation alert dosimeter JP LABORATORIES, INC (US) 2015-07-21 US disclosed
US-8872134-B2 Self indicating radiation alert dosimeter JP LABORATORIES, INC (US) 2014-10-28 US disclosed
WO-2013014445-A1 DERIVATIVES OF PHENYL (THIO) UREA DEOXYTHYMIDINE AND USE THEREOF AS ANTIMALARIALS UNIVERSITY OF DUNDEE (GB) 2013-01-31 WO disclosed
US-20120205591-A1 SELF INDICATING RADIATION ALERT DOSIMETER PATEL GORDHABHAI N (US) 2012-08-16 US disclosed
US-20120181453-A1 PERSONAL AND AREA SELF-INDICATING INSTANT RADIATION ALERT DOSIMETER JP LABORATORIES INC. 2012-07-19 US disclosed
US-8115182-B1 Personal and area self-indicating radiation alert dosimeter JP LABORATORIES INC. 2012-02-14 US disclosed
US-6635489-B2 Sensitizing the matrix with heteroaromatic compounds, contacting with reduceable metal salts to stain and detecting INVITROGEN CORPORATION 2003-10-21 US disclosed
EP-1344055-A1 MATERIALS FOR ENHANCING STAINING OF BIOPOLYMERS IN MATRICES INVITROGEN CORPORATION (US) 2003-09-17 EP disclosed
WO-2003024967-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA S.A. (FR) 2003-03-27 WO disclosed
US-20020137222-A1 Materials for enhancing staining of biopolymers in matrices INVITROGEN CORPORATION 2002-09-26 US disclosed
US-6410598-B1 ALZHEIMER'S DISEASE; CENTRAL NERVOUS SYSTEM DISORDERS SYNVISTA THERAPEUTICS, INC. 2002-06-25 US disclosed
WO-2002042764-A1 MATERIALS FOR ENHANCING STAINING OF BIOPOLYMERS IN MATRICES INVITROGEN CORPORATION (US) 2002-05-30 WO disclosed
US-6362342-B1 BIOSYNTHESIS; DRUG LIBRARIES LION BIOSCIENCE AG (DE) 2002-03-26 US disclosed
US-5935927-A Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1999-08-10 US disclosed
EP-0802797-A1 COMPOSITIONS AND METHODS FOR ADVANCED GLYCOSYLATION ENDPRODUCT-MEDIATED MODULATION OF AMYLOIDOSIS THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1997-10-29 EP disclosed
WO-1995020979-A1 COMPOSITIONS AND METHODS FOR ADVANCED GLYCOSYLATION ENDPRODUCT-MEDIATED MODULATION OF AMYLOIDOSIS THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1995-08-10 WO disclosed